The global Tuberculosis Drugs Therapeutics Market witnessed a size of USD 1.42 billion in 2022, with an anticipated expansion to USD 2.65 billion by 2032, reflecting a substantial compound annual growth rate (CAGR) of 7.2% throughout the forecast period. The primary impetus for this market's revenue surge is the escalating prevalence of tuberculosis on a global scale, especially in developing...